{"Q": 1, "answer": "no", "rationale": "No intensifier or comparative directly modifies a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_9168", "batch_size": 260, "batch_pos": 235, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment reports on a deal and scale factually.", "method": "llm_batch", "batch_id": "batch_2_15668", "batch_size": 260, "batch_pos": 222, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "The segment reports securing doses and an option for more, which is a neutral fact + numbers.", "method": "llm_batch", "batch_id": "batch_3_15468", "batch_size": 260, "batch_pos": 168, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_14080", "batch_size": 260, "batch_pos": 153, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "Reports facts about a deal and vaccine doses.", "method": "llm_batch", "batch_id": "batch_5_14184", "batch_size": 260, "batch_pos": 150, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "The segment provides numbers of vaccine doses secured but does not use a minimiser in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_7576", "batch_size": 260, "batch_pos": 124, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_2480", "batch_size": 260, "batch_pos": 113, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes securing resources/capability ('secures up to 665,000 doses', 'includes an option for a further 40 million vaccines') without linking to current calm/safety.", "method": "llm_batch", "batch_id": "batch_8_19256", "batch_size": 260, "batch_pos": 32, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
